Zio Demand Drives 20% Revenue Growth For iRhythm, Bullish Sentiment Builds Among Analysts
iRhythm raises 2025 sales forecast and launches Zio ECG system in Japan as analysts boost ratings and price targets on strong Q1 performance. Latest Ratings for IRTC Date Firm Action From To Feb 2022 Morgan Stanley Maintains Overweight Feb 2022 Needham Upgrades Hold Buy Jan 2022 JP Morgan Maintains Overweight View More Analyst Ratings for…